Exclusive

Publication

Byline

Maruti Suzuki Commissions 300 kW Green Hydrogen Plant At Manesar Facility

Mumbai, Sept. 24 -- Maruti Suzuki India, the country's largest passenger vehicle manufacturer, has commissioned a 300 kW green hydrogen electrolyser plant as a pilot project at its Manesar facility in... Read More


Google-Kantar Study Finds 93% Of Indian Car Buyers Use AI Tools During Vehicle Research

Mumbai, Sept. 24 -- A study conducted by Google and Kantar titled 'Automobile Purchase Journey in the Age of AI' shows that 93 percent of automobile shoppers in India utilise artificial intelligence (... Read More


Tata Power EZ Charge Opens New EV Charging Hub In Mumbai

Mumbai, Sept. 24 -- Tata Power EZ Charge has commissioned an electric vehicle charging hub at New Mahakali Nagar in Malvani, Malad West, Mumbai. The facility comprises eight parking bays and four fas... Read More


Horn Not Ok Please

Mumbai, Sept. 24 -- People keep commuting around the city and across towns every day for work, meetings and other reasons. Many of these people travel by road, either personal transportation, taxis / ... Read More


Melbourne joins global consortium to advance drug discovery

Singapore, Sept. 24 -- The University of Melbourne has joined the Structural Genomics Consortium (SGC) with the establishment of SGC-Melbourne, a new SGC Affiliated Site and the consortium's only site... Read More


"Minimally invasive therapies are reshaping the treatment landscape for structural heart disease, particularly for older or medically complex patients"

India, Sept. 24 -- image credit- freepik Tricuspid regurgitation has long been labelled the "forgotten valve disease". What has historically kept TR out of mainstream cardiovascular discussions, and ... Read More


Innovation in CAR T-Cell Therapy: Making Treatment Faster and More Accessible

India, Sept. 24 -- Pixabay The science behind car t-cell therapy has already been proven. What's harder now is the logistics side of things; actually getting this treatment to more patients, faster, ... Read More


Novo Nordisk receives Singapore approval for Wegovy(R) as first treatment for MASH with liver fibrosis

Singapore, Sept. 24 -- Novo Nordisk has announced that Singapore's Health Sciences Authority (HSA) has approved Wegovy(R) (once-weekly injectable semaglutide 2.4 mg) as the first approved treatment in... Read More


NUS Enterprise evolves into NUSX to expand global pathways for deep tech ventures

Singapore, Sept. 24 -- NUS Enterprise, the entrepreneurial heart of the National University of Singapore, has unveiled its next chapter as NUSX. The new identity reflects its evolution into an integr... Read More


Mayo Clinic Laboratories invests in Pathology Asia Holdings and LifeStrands Genomics to expand precision medicine in APAC

Singapore, Sept. 24 -- Mayo Clinic Laboratories and Pathology Asia Holdings have announced a strategic investment and collaboration aimed at expanding access to advanced diagnostics and precision medi... Read More